Yes - I know that Acadia has chosen not to make the precise time for the results public but they may give some indication in tomorrows announcement about the timing. The trofinetide results WILL BE OUT BEFORE THE END OF DECEMBER. Neuren have stated re trofinetide that "Everything is on track".
As for the response to the FDA regarding Angelman, Neuren are compiling it and although they were frustrated by this requirement, they are confident that they will be able to move forward. This was the primary reason for the Capital Raising - being able to self fund development of the 2591 product.
So "Everything is on track" for trofinetide - if you back the science and the testing done to date - you should be holding on to your shares and I think we can see that is the case for many with the low turnover. The capital raising may have done more damage than expected, however, only in the short term.
I for one have been buying on the dips over the past few weeks - especially today - and my average is still below $1.55 per share. but my holdings are now significantly larger.
GLTAH - if you trust the science, like I do - hold on for the trofinetide results sometime over the next 7 weeks and the ride ahead, but DYOR.
Share Price, page-82
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.47 |
Change
0.080(0.41%) |
Mkt cap ! $2.486B | |||
| Open | High | Low | Value | Volume |
| $19.58 | $19.85 | $19.23 | $9.536M | 488.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1770 | $19.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.49 | 348 | 1 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.51 |
Change
0.080 ( 0.62 %) |
||||
| Open | High | Low | Volume | ||
| $19.60 | $19.82 | $19.24 | 217738 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| NEU (ASX) Chart |